Dr. Federico Demarchi graduated in Pharmacy from the University of Turin and subsequently completed a Specialisation in Hospital Pharmacy at the same university. He further developed his professional expertise by attending the Advanced Training Course in Health Technology Assessment (COPHTA) at LIUC Business School.
During his training, he completed internships and professional placements at A.O.U. Città della Salute e della Scienza di Torino. He was also awarded two scholarships from the University of Turin, focusing on monitoring the use of monoclonal antibodies and on the Health Technology Assessment (HTA) of medical devices in the oncology setting.
He has served as a speaker at courses and seminars on Health Technology Assessment and venous access management.
He is a member of the SIFO Scientific and Cultural Area for Advanced Therapies, Biotechnology, Pharmacogenetics and Pharmacogenomics.
He is the author and co author of scientific publications and contributions presented at national conferences.